Metastatic melanoma (stage III) and lymph node dissection at a university hospital facility

Metastatic melanoma (stage III) and lymph node dissection at a university hospital facility Eur J Plast Surg (2017) 40:127–132 DOI 10.1007/s00238-016-1234-2 ORIGINAL PAPER Metastatic melanoma (stage III) and lymph node dissection at a university hospital facility 1,2 1 1 Ulrik K Kjerkegaard & Pia Sjøgren & Lars B Stolle Received: 3 May 2016 /Accepted: 7 August 2016 /Published online: 16 August 2016 Springer-Verlag Berlin Heidelberg 2016 Abstract neck (11.1 %). The 5-year nodal recurrence rate was 16.9 % Background Malign melanoma continues to present a severe [95 % CI 8.2–33.1 %] and the 5-year rate of distant metastases health problem, and the incidence is still raising. Nodal status was 48.3 % [95 % CI 36.5–61.8 %]. Overall survival was and ulceration of the primary melanoma are strong prognostic 51.8 % [95 % CI 35.6–65.8 %]. More than two nodal metas- factors. The main treatment of node-positive melanomas tases worsened the prognosis (reference: <2 lymph nodes). (stage III) is complete lymph node dissection. The aim of this Level of Evidence: Level IV, risk/prognostic study. study was to describe the outcome in patients with stage III melanoma who underwent completion lymphadenectomy at a Keywords Stage III melanoma Completion lymph node . . department of plastic surgery. dissection Complications Prognosis Methods Retrospectively, we included all http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Plastic Surgery Springer Journals

Metastatic melanoma (stage III) and lymph node dissection at a university hospital facility

Loading next page...
 
/lp/springer_journal/metastatic-melanoma-stage-iii-and-lymph-node-dissection-at-a-I86bMeBjiW
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2016 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Plastic Surgery
ISSN
0930-343X
eISSN
1435-0130
D.O.I.
10.1007/s00238-016-1234-2
Publisher site
See Article on Publisher Site

Abstract

Eur J Plast Surg (2017) 40:127–132 DOI 10.1007/s00238-016-1234-2 ORIGINAL PAPER Metastatic melanoma (stage III) and lymph node dissection at a university hospital facility 1,2 1 1 Ulrik K Kjerkegaard & Pia Sjøgren & Lars B Stolle Received: 3 May 2016 /Accepted: 7 August 2016 /Published online: 16 August 2016 Springer-Verlag Berlin Heidelberg 2016 Abstract neck (11.1 %). The 5-year nodal recurrence rate was 16.9 % Background Malign melanoma continues to present a severe [95 % CI 8.2–33.1 %] and the 5-year rate of distant metastases health problem, and the incidence is still raising. Nodal status was 48.3 % [95 % CI 36.5–61.8 %]. Overall survival was and ulceration of the primary melanoma are strong prognostic 51.8 % [95 % CI 35.6–65.8 %]. More than two nodal metas- factors. The main treatment of node-positive melanomas tases worsened the prognosis (reference: <2 lymph nodes). (stage III) is complete lymph node dissection. The aim of this Level of Evidence: Level IV, risk/prognostic study. study was to describe the outcome in patients with stage III melanoma who underwent completion lymphadenectomy at a Keywords Stage III melanoma Completion lymph node . . department of plastic surgery. dissection Complications Prognosis Methods Retrospectively, we included all

Journal

European Journal of Plastic SurgerySpringer Journals

Published: Aug 16, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off